M K Proteins financials

·FMCG & RetailChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹115cr+0.2% on Q1 FY26
Net profit
₹1.4cr−60.7% on Q1 FY26
EBITDA margin
2.2%−2.6 pts on Q1 FY26
EPS
₹0.04−55.6% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue115115+0.2%
EBITDA2.55.5−54.4%
EBITDA margin2.2%4.8%−2.6 pts
Profit before tax1.84.7−60.7%
Net profit1.43.5−60.7%
EPS₹0.04₹0.09−55.6%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹115 crNet profit₹1.4 crNet margin1.2%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024
137———
0.40.40.00.1
36.236.237.819.1
173———
383383268246
—+43.0%+9.0%—
8.411.412.416.6
2.2%3.0%4.6%6.8%
7.911.012.116.1
4.76.88.411.2
1.2%1.8%3.1%4.6%
₹0.13₹0.18₹0.22₹0.30
—−18.7%−25.1%—
—5.4−16.132.4
—−1.9−2.2−5.9
3.53.5−18.426.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MKPL₹3.65

M K Proteins Limited

· FMCG & Retail
₹ CrorePeersROMLHALDERNKINDGOKULKRITINUTSUNDROPMcap ₹137 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization———137.0
- Cash, Equiv & ST Investments0.10.00.40.4
+ Total Debt19.137.836.236.2
Enterprise Value———172.8
Revenue245.6267.7382.9383.1
Growth %, YoY—+9.0+43.0—
EBITDA16.612.411.48.4
Margin %6.774.642.982.20
EBIT16.112.111.07.9
Net Income11.28.46.84.7
Margin %4.573.141.781.23
EPS, Adj (current shares)0.300.220.180.13
Growth %, YoY—-25.1-18.7—
Cash from Operations32.4-16.15.4—
Capital Expenditures-5.9-2.2-1.9—
Free Cash Flow26.5-18.43.53.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

M K Proteins financials and key ratios

Prices at the previous close · figures from the company's filings with NSE

M K Proteins (NSE: MKPL) had a market capitalisation of ₹137 crore at the previous close (₹3.65 a share), a PE ratio of 29.2 on the last four quarters' profit and a price-to-book ratio of 1.80. In FY26 its consolidated net profit was ₹6.8 crore on revenue of ₹383 crore; in Q1 FY27 (April–June 2026) it was ₹1.4 crore, down 60.7% year on year. Its debt-to-equity ratio was 0.47 on 31 March 2026. Promoters held 74.82% of the shares on 30 September 2026.

M K Proteins Q1 FY27 results
filed 13 August 2026
Share price used
₹3.65 · previous close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

M K Proteins at a glance · consolidated

Market cap
₹137 Crat ₹3.65 · previous close
PE ratio (last 4 quarters)
29.220.1 on FY26 profit
Price to book (PB)
1.80book value ₹2.03 a share
ROE (FY26)
9.4%−3.5 pts vs FY25ROCE 14.6%
Debt to equity
0.47net debt ₹35.8 Cr
Promoter holding
74.82%unchanged vs 30 Jun 202630 September 2026
Net worth
₹76.3 Cr+9.8% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹3.5 Cr
EPS (FY26)
₹0.18

Questions

What is the M K Proteins PE ratio today?

M K Proteins' PE ratio is 29.2 at the previous close (₹3.65 a share): a market capitalisation of ₹137 crore divided by consolidated net profit of ₹4.7 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹6.8 crore) it is 20.1.

What is the M K Proteins net worth?

M K Proteins' net worth — shareholders' equity in its consolidated balance sheet — was ₹76.3 crore on 31 March 2026, up 9.8% from ₹69.5 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹137 crore at the previous close.

What is the M K Proteins book value per share?

M K Proteins' book value per share was ₹2.03 on 31 March 2026: shareholders' equity of ₹76.3 crore divided by the 37.54 crore shares in issue, up 9.8% from ₹1.85 a year earlier. The share price at the previous close was ₹3.65.

What is the M K Proteins PB ratio (price to book value)?

M K Proteins' price-to-book (PB) ratio is 1.80 at the previous close: a market capitalisation of ₹137 crore divided by shareholders' equity (book value) of ₹76.3 crore on 31 March 2026. That is a book value of ₹2.03 per share against a share price of ₹3.65.

What is the M K Proteins ROE and ROCE?

In FY26, M K Proteins' return on equity (ROE) was 9.4% and its return on capital employed (ROCE) was 14.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 12.9% and ROCE 18.1%.

What is the M K Proteins free cash flow?

In FY26, M K Proteins generated ₹5.4 crore of cash from operations and spent ₹1.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹3.5 crore. In FY25 it was −₹18.4 crore.

What is the M K Proteins market cap?

M K Proteins' market capitalisation was ₹137 crore at the previous close: 37.54 crore shares at ₹3.65 each.

What is the M K Proteins EPS?

M K Proteins' basic earnings per share (EPS) were ₹0.18 in FY26, against ₹0.22 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.13.

What is the M K Proteins shareholding pattern?

On 30 September 2026, M K Proteins' shares were held by promoters 74.82% and retail and other non-institutional investors 25.18%.

Is M K Proteins debt free?

No. M K Proteins had borrowings of ₹36.2 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.47. Its cash and current investments were ₹44 lakh, so its net debt was ₹35.8 crore.

What is the M K Proteins debt to equity ratio?

M K Proteins' debt-to-equity ratio was 0.47 on 31 March 2026: borrowings of ₹36.2 crore against total equity of ₹76.3 crore. A year earlier, on 31 March 2025, it was 0.54.

What is the M K Proteins promoter holding?

Promoters held 74.82% of M K Proteins on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What are the M K Proteins latest quarterly results?

M K Proteins' latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹1.4 crore, down 60.7% from ₹3.5 crore in Q1 FY26; revenue from operations ₹115 crore, up 0.2% year on year.

What is the M K Proteins revenue and profit in FY26?

In FY26 (April 2025–March 2026), M K Proteins' consolidated net profit was ₹6.8 crore, down 18.7% from ₹8.4 crore in FY25, on revenue from operations of ₹383 crore (up 43.0%).

M K Proteins vs Raj Oil Mills: how do they compare?

In FY26, M K Proteins earned net profit of ₹6.8 crore on revenue of ₹383 crore, against ₹4.7 crore on ₹151 crore for Raj Oil Mills. M K Proteins' operating margin was 2.9% (Raj Oil Mills 3.6%) and its return on equity 9.4% (Raj Oil Mills −3,248.4%).

When are the M K Proteins next results?

M K Proteins has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

How does M K Proteins compare with its peers?

On FY26 consolidated figures, against Raj Oil Mills, Halder Venture and NK Industries: M K Proteins' operating margin of 2.9% is the third highest of the four (Raj Oil Mills 3.6%, Halder Venture 3.4%, NK Industries −33.2%; peer average −8.7%).

Where do these M K Proteins figures come from?

From M K Proteins' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.